
Intactis Bio builds biological computers that use living neural tissue to perform ultra-efficient computation for energy-constrained workloads. The company fabricates proprietary engineered neural tissue and pairs it with a brain–machine interface and a biocomputation platform to run AI/ML and data-processing tasks. Its offering is positioned as a B2B SaaS-like model with alpha programs and data modeling services for AI companies and data centers. Core technologies include neural tissue engineering, brain–machine interfaces, neuromorphic biocomputation, and AI/ML integration. The approach targets high-performance computing and drug-discovery markets where lower energy use and novel compute architectures provide competitive advantage.

Intactis Bio builds biological computers that use living neural tissue to perform ultra-efficient computation for energy-constrained workloads. The company fabricates proprietary engineered neural tissue and pairs it with a brain–machine interface and a biocomputation platform to run AI/ML and data-processing tasks. Its offering is positioned as a B2B SaaS-like model with alpha programs and data modeling services for AI companies and data centers. Core technologies include neural tissue engineering, brain–machine interfaces, neuromorphic biocomputation, and AI/ML integration. The approach targets high-performance computing and drug-discovery markets where lower energy use and novel compute architectures provide competitive advantage.